Literature DB >> 23065719

A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder.

Erik G Puffenberger1, Robert N Jinks, Heng Wang, Baozhong Xin, Christopher Fiorentini, Eric A Sherman, Dominick Degrazio, Calvin Shaw, Carrie Sougnez, Kristian Cibulskis, Stacey Gabriel, Richard I Kelley, D Holmes Morton, Kevin A Strauss.   

Abstract

We studied a unique phenotype of cognitive delay, autistic behavior, and gait instability segregating in three separate sibships. We initiated genome-wide mapping in two sibships using Affymetrix 10K SNP Mapping Arrays and identified a homozygous 8.2 Mb region on chromosome 15 common to five affected children. We used exome sequencing of two affected children to assess coding sequence variants within the mapped interval. Four novel homozygous exome variants were shared between the two patients; however, only two variants localized to the mapped interval on chromosome 15. A third sibship in an Ohio Amish deme narrowed the mapped interval to 2.6 Mb and excluded one of the two novel homozygous exome variants. The remaining variant, a missense change in HERC2 (c.1781C>T, p.Pro594Leu), occurs in a highly conserved proline residue within an RCC1-like functional domain. Functional studies of truncated HERC2 in adherent retinal pigment epithelium cells suggest that the p.Pro594Leu variant induces protein aggregation and leads to decreased HERC2 abundance. The phenotypic correlation with the mouse Herc1 and Herc2 mutants as well as the phenotypic overlap with Angelman syndrome provide further evidence that pathogenic changes in HERC2 are associated with nonsyndromic intellectual disability, autism, and gait disturbance. Hum Mutat 33:1639-1646, 2012.
© 2012 Wiley Periodicals, Inc. © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065719     DOI: 10.1002/humu.22237

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  45 in total

1.  Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.

Authors:  C Toma; B Torrico; A Hervás; R Valdés-Mas; A Tristán-Noguero; V Padillo; M Maristany; M Salgado; C Arenas; X S Puente; M Bayés; B Cormand
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

2.  Dual molecular diagnosis contributes to atypical Prader-Willi phenotype in monozygotic twins.

Authors:  Fernanda S Jehee; Valdirene T de Oliveira; Juliana Gurgel-Giannetti; Rafaella X Pietra; Fernando V M Rubatino; Natália V Carobin; Gabrielle S Vianna; Mariana L de Freitas; Karla S Fernandes; Beatriz S V Ribeiro; Hennie T Brüggenwirth; Roza Ali-Amin; Janson J White; Zeynep C Akdemir; Shalini N Jhangiani; Richard A Gibbs; James R Lupski; Monica C Varela; Célia Koiffmann; Carla Rosenberg; Cláudia M B Carvalho
Journal:  Am J Med Genet A       Date:  2017-06-20       Impact factor: 2.802

3.  The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization.

Authors:  Monica Cubillos-Rojas; Fabiola Amair-Pinedo; Roser Peiró-Jordán; Ramon Bartrons; Francesc Ventura; Jose Luis Rosa
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

4.  Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes.

Authors:  Gustavo Martínez-Noël; Katja Luck; Simone Kühnle; Alice Desbuleux; Patricia Szajner; Jeffrey T Galligan; Diana Rodriguez; Leon Zheng; Kathleen Boyland; Flavian Leclere; Quan Zhong; David E Hill; Marc Vidal; Peter M Howley
Journal:  J Mol Biol       Date:  2018-02-06       Impact factor: 5.469

5.  Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay.

Authors:  Tatsuaki Kurosaki; Naoto Imamachi; Christoph Pröschel; Shuhei Mitsutomi; Rina Nagao; Nobuyoshi Akimitsu; Lynne E Maquat
Journal:  Nat Cell Biol       Date:  2021-01-08       Impact factor: 28.824

6.  Transcriptome study of differential expression in schizophrenia.

Authors:  Alan R Sanders; Harald H H Göring; Jubao Duan; Eugene I Drigalenko; Winton Moy; Jessica Freda; Deli He; Jianxin Shi; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2013-07-30       Impact factor: 6.150

7.  High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders.

Authors:  Tarunashree Yavarna; Nader Al-Dewik; Mariam Al-Mureikhi; Rehab Ali; Fatma Al-Mesaifri; Laila Mahmoud; Noora Shahbeck; Shenela Lakhani; Mariam AlMulla; Zafar Nawaz; Patrik Vitazka; Fowzan S Alkuraya; Tawfeg Ben-Omran
Journal:  Hum Genet       Date:  2015-06-16       Impact factor: 4.132

8.  HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism.

Authors:  Toshiro Moroishi; Takayoshi Yamauchi; Masaaki Nishiyama; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

9.  Complete loss of function of the ubiquitin ligase HERC2 causes a severe neurodevelopmental phenotype.

Authors:  Fanny Morice-Picard; Giovanni Benard; Hamid R Rezvani; Eulalie Lasseaux; Delphine Simon; Sébastien Moutton; Caroline Rooryck; Didier Lacombe; Clarisse Baumann; Benoit Arveiler
Journal:  Eur J Hum Genet       Date:  2016-10-19       Impact factor: 4.246

Review 10.  Functional and pathological relevance of HERC family proteins: a decade later.

Authors:  Susana Sánchez-Tena; Monica Cubillos-Rojas; Taiane Schneider; Jose Luis Rosa
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.